Anticoagulant Market

23 May


Anticoagulant Market Poised to Grow at a CAGR of 6.9% by 2024

  • By admin

  • January, 1970

Infinium Global Research has added a new report on Anticoagulant Market. The report presents analysis of global as well as regional markets of anticoagulant market over the period of 2018 to 2024.

Global Anticoagulant market is showing a positive trend of growth around the globe. There are many factors which are indicating a positive outlook of this market for medium and long term. The increasing aging population is a key driver for the global anticoagulants market. Also, increasing investment in R&D in the pharmaceutical sector and the introduction of innovative oral anticoagulants drugs are expediting the growth of this market. Stringent regulations implemented by many governments for health safety reason could hamper the growth of the global anticoagulants market in short and medium term. Moreover, risk of side-effects and complications associated with anticoagulants also hinders growth of the global anticoagulants market. Moreover, due to increasing awareness about therapeutic applications of anticoagulants in different disease among the physicians and surgeons around the globe could further drive the market globally.


On the basis of region, the Anti-coagulant market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America dominates the global anticoagulants market. Asia region is expected to grow at the fastest CAGR during the forecast period. China and India are the major countries responsible for driving growth in the Asia Pacific region due to increasing demand for better medical infrastructure, increasing healthcare spending among middle and working class people and governments initiatives to provide better health care services to its citizens. Furthermore, rising awareness about the use of anti-coagulant medicine and therapy among physicians, doctors and common persons, are some major driving force of the anticoagulant market in this regional segment April, 2018; Popular ASRA Coags app  has been updated with lots of new features, which helps the physicians to protect the patients taking anticogulents. Now, it also has updated list of regional anesthesia/acute pain medicine and chronic pain medicine drugs, procedures, and interventions, which will help to end users to know the latest medicine for their disease easily.


Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global anticoagulant market but also make strategic decisions to capture the most lucrative markets in the near future. The market size is presented in terms of value for the historic year 2018 and estimated for forecast period of 2016-2024.


Get 15% discount for early purchase of global anticoagulant market report by clicking the following link, Use code IGRD15 to request the discount in the given form


The recent report identified that North America dominated the global anticoagulant market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the anticoagulant market worldwide.


The report segments the global anticoagulant market on the basis of ROA, Anticoagulant drugs, Applications and Drug class.


Global Anticoagulant Market by ROA

·         Oral Anticoagulants

·         Injectable Anticoagulants


Global Anticoagulant Market by Anticoagulant Drugs

·         Betrixaban

·         Dabigatran (Pradaxa)

·         Edoxaban, Rivaroxaban (Xarelto)

·         Eliquis (Apixaban)


Global Anticoagulant Market by Applications

·         Cardiovascular Diseases

·         Coronary Artery Diseases

·         Cardiac Arrhythmia

·         Myocardial Infarction

·          DVT

·         Heart Valve Replacement


Global Anticoagulant Market by Drug Class

·         Factor Xa Inhibitors

·         DTIs

·         Heparin

·         Vitamin K Antagonists


Companies Profiled in the Report

·         Johnson & Johnson

·         Sanofi

·         AstraZeneca

·         Eli Lilly

·         Keryx Biopharmaceuticals

·         LEO Pharma

·         Pfizer

·         The Medicines Company

·         Bayer HealthCare

·         BoehringerIngelheim


About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.